Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lars Viktrup

Showing results (11-20 of 111) with videos related to

Pageof 12
Sort By:
American Journal of Obstetrics and Gynecology|February 5, 2008
Does the impact of subsequent incontinence risk factors depend on continence status during the first pregnancy or the postpartum period 12 years before? A cohort study in 232 primiparous womenLars Viktrup, Guri Rortveit, Gunnar Lose
Primary Care Companion to the Journal of Clinical Psychiatry|December 23, 2004
Duloxetine Treatment of Stress Urinary Incontinence in Women Does Not Induce Mania or HypomaniaLars Viktrup, David G Perahia, Andre Tylee
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|August 11, 2004
Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: a US focused reviewLars Viktrup, Kent H Summers, Susan L Dennett
Drugs|July 6, 2004
Pharmacotherapy for stress urinary incontinence : present and future optionsNorman R Zinner, Stephanie C Koke, Lars Viktrup
Neurourology and Urodynamics|May 29, 2009
Reductions in stress urinary incontinence episodes: what is clinically important for women?Ilker Yalcin, Guangbin Peng, Lars Viktrup, et al.
BMC Musculoskeletal Disorders|February 2, 2022
Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritisPhilip G Conaghan, Lucy Abraham, Lars Viktrup, et al.
BMC Urology|November 9, 2012
Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasiaLars Viktrup, Risa P Hayes, Ping Wang, et al.
Lower Urinary Tract Symptoms|December 18, 2015
Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label ExtensionMasayuki Takeda, Osamu Nishizawa, Takeshi Imaoka, et al.
World Journal of Urology|August 8, 2014
Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness SurveyShonda A Foster, Emily F Shortridge, Marco DiBonaventura, et al.
Southern Medical Journal|February 1, 2005
Stress urinary incontinence in active elderly womenLars Viktrup, Stephanie Koke, Kathryn L Burgio, et al.
Pageof 12

Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
American Journal of Obstetrics and Gynecology|February 5, 2008
Does the impact of subsequent incontinence risk factors depend on continence status during the first pregnancy or the postpartum period 12 years before? A cohort study in 232 primiparous womenLars Viktrup, Guri Rortveit, Gunnar Lose
Primary Care Companion to the Journal of Clinical Psychiatry|December 23, 2004
Duloxetine Treatment of Stress Urinary Incontinence in Women Does Not Induce Mania or HypomaniaLars Viktrup, David G Perahia, Andre Tylee
International Journal of Gynaecology and Obstetrics: the Official Organ of the International Federation of Gynaecology and Obstetrics|August 11, 2004
Clinical practice guidelines on the initial assessment and treatment of urinary incontinence in women: a US focused reviewLars Viktrup, Kent H Summers, Susan L Dennett
Drugs|July 6, 2004
Pharmacotherapy for stress urinary incontinence : present and future optionsNorman R Zinner, Stephanie C Koke, Lars Viktrup
Neurourology and Urodynamics|May 29, 2009
Reductions in stress urinary incontinence episodes: what is clinically important for women?Ilker Yalcin, Guangbin Peng, Lars Viktrup, et al.
BMC Musculoskeletal Disorders|February 2, 2022
Impact of tanezumab on health status, non-work activities and work productivity in adults with moderate-to-severe osteoarthritisPhilip G Conaghan, Lucy Abraham, Lars Viktrup, et al.
BMC Urology|November 9, 2012
Construct validation of patient global impression of severity (PGI-S) and improvement (PGI-I) questionnaires in the treatment of men with lower urinary tract symptoms secondary to benign prostatic hyperplasiaLars Viktrup, Risa P Hayes, Ping Wang, et al.
Lower Urinary Tract Symptoms|December 18, 2015
Tadalafil for the Treatment of Lower Urinary Tract Symptoms in Japanese Men with Benign Prostatic Hyperplasia: Results from a 12-week Placebo-controlled Dose-finding Study with a 42-week Open-label ExtensionMasayuki Takeda, Osamu Nishizawa, Takeshi Imaoka, et al.
World Journal of Urology|August 8, 2014
Predictors of self-reported benign prostatic hyperplasia in European men: analysis of the European National Health and Wellness SurveyShonda A Foster, Emily F Shortridge, Marco DiBonaventura, et al.
Southern Medical Journal|February 1, 2005
Stress urinary incontinence in active elderly womenLars Viktrup, Stephanie Koke, Kathryn L Burgio, et al.
Pageof 12